Abstract
Purpose
Metastasis-associated in colon cancer-1 (MACC1) is a newly identified gene that plays an important role in cancer progression and metastasis. MACC1 has important functions in the differentiation, invasion, and metastasis of nonsmall cell lung cancer (NSCLC). However, the value of circulating MACC1 as a potential diagnostic and prognostic biomarker for NSCLC remains unknown.
Methods
Plasma MACC1 mRNA levels were examined in 272 patients with NSCLC, 61 with benign lung disease, and 80 healthy volunteers using reverse transcription quantitative real-time polymerase chain reaction.
Results
MACC1 was more highly expressed in NSCLC patients than in patients with benign disease (P < 0.001) or in healthy volunteers (P < 0.001). High MACC1 expression was significantly associated with NSCLC stage (P = 0.013) and lymph node metastasis (P = 0.016). The area under the receiver operating characteristic curve was 0.766, and the optimal cutoff value was 0.105, providing a sensitivity of 71.4 % and a specificity of 89.1 %. The diagnostic capability of circulating MACC1 mRNA was higher than that of carcinoembryonic antigen (P = 0.025) or cytokeratin-19 (P = 0.010). Furthermore, high MACC1 expression was associated with poor overall survival (OS) and disease-free survival (DFS) and predicted poor survival in NSCLC patients. Consequently, MACC1 mRNA was an independent prognostic factor of OS and DFS.
Conclusion
We concluded that circulating MACC1 mRNA represents a potential noninvasive, diagnostic and prognostic marker for NSCLC.
Similar content being viewed by others
References
Alberg AJ, Ford JG, Samet JM, American College of Chest P (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29S–55S. doi:10.1378/chest.07-1347
Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41:2356–2359. doi:10.1016/j.biocel.2009.08.001
Arya SK, Bhansali S (2011) Lung cancer and its early detection using biomarker-based biosensors. Chem Rev 111:6783–6809. doi:10.1021/cr100420s
Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1:36. doi:10.1186/gm36
Cabrera-Alarcon JL, Carrillo-Vico A, Santotoribio JD, Leon-Justel A, Sanchez-Gil R, Gonzalez-Castro A, Guerrero JM (2011) CYFRA 21-1 as a tool for distant metastasis detection in lung cancer. Clin Lab 57:1011–1014
Cho JY, Sung HJ (2009) Proteomic approaches in lung cancer biomarker development. Expert Rev Proteomics 6:27–42. doi:10.1586/14789450.6.1.27
Chundong G et al (2011) Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31:1141–1145
Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, Jandrig B (2001) Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 945:179–188
Gahan PB (2010) Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J 1:503–512. doi:10.1007/s13167-010-0021-6
Gridelli C, Rossi A, Maione P (2011) 2010 Consensus on lung cancer, new clinical recommendations and current status of biomarker assessment—first-line therapy. Eur J Cancer 47(Suppl 3):s248–s257. doi:10.1016/S0959-8049(11)70171-X
Guo T, Yang J, Yao J, Zhang Y, Da M, Duan Y (2013) Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int 13:121. doi:10.1186/1475-2867-13-121
Hagemann C et al (2013) Impact of MACC1 on human malignant glioma progression and patients’ unfavorable prognosis. Neurooncol 15:1696–1709. doi:10.1093/neuonc/not136
Holdenrieder S, Nagel D, Stieber P (2010) Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer. Cancer Biomark 6:179–190. doi:10.3233/CBM-2009-0128
Hu X, Fu X, Wen S, Zou X, Liu Y (2012) Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer. Chin J Lung Cancer 15:399–403. doi:10.3779/j.issn.1009-3419.2012.07.02
Huang J, Wang K, Xu J, Huang J, Zhang T (2013a) Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PloS One 8:e78070. doi:10.1371/journal.pone.0078070
Huang Y et al (2013b) Overexpression of MACC1 and its significance in human. Breast Cancer Progress Cell Biosci 3:16. doi:10.1186/2045-3701-3-16
Isella C et al (2013) MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg 257:1089–1095. doi:10.1097/SLA.0b013e31828f96bc
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107
Kawamura M et al (2012) Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res 32:1527–1531
Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz LS (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317–323
Kopreski MS, Benko FA, Kwak LW, Gocke CD (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5:1961–1965
Lo KW et al (1999) Analysis of cell-free Epstein-barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 45:1292–1294
Meng F et al (2013) MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One 8:e60821. doi:10.1371/journal.pone.0060821
Muinelo-Romay L et al (2014) Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment. Cancers 6:153–165. doi:10.3390/cancers6010153
Qiu J et al (2011) Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9:166. doi:10.1186/1479-5876-9-166
Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, Yasumoto K (2011) Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 141:895–898. doi:10.1016/j.jtcvs.2010.09.044
Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236. doi:10.3322/caac.20121
Stein U et al (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59–67. doi:10.1038/nm.1889
Stein U, Dahlmann M, Walther W (2010) MACC1—more than metastasis? Facts and predictions about a novel gene. J Mol Med 88:11–18. doi:10.1007/s00109-009-0537-1
Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM (2011) Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients. J Mol Diagn 13:189–198. doi:10.1016/j.jmoldx.2010.10.002
Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM (2012) Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One 7:e49249. doi:10.1371/journal.pone.0049249
Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y (2011) Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 137:1151–1173. doi:10.1007/s00432-011-0988-y
Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL (2012) MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 4:783–791. doi:10.3892/ol.2012.784
Wang L et al (2013) Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer 133:1419–1430. doi:10.1002/ijc.28140
Wang Z et al (2014) MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol 31:790. doi:10.1007/s12032-013-0790-6
Xie C et al (2013) MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 8:e64235. doi:10.1371/journal.pone.0064235
Yang T et al (2013) Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumour Biol. doi:10.1007/s13277-013-1112-5
Zhang RT, Shi HR, Huang HL, Chen ZM, Liu HN, Yuan ZF (2011) Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance. J South Med Univ 31:1551–1555
Zhang X et al (2012) Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer 131:165–172. doi:10.1002/ijc.26360
Zhang K et al (2013a) MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. doi:10.1007/s13277-013-1335-5
Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C, Zhu Q (2013b) High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour Biol. doi:10.1007/s13277-013-1180-6
Zhu M, Xu Y, Mao X, Gao Y, Shao L, Yan F (2013) Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res 19:749–753. doi:10.1007/s12253-013-9638-9
Acknowledgments
We would like to thank Yonggong Wang, Yang Xia, and Jiajie Hou from Nanjing Medical University for technical assistance.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Z., Cai, M., Weng, Y. et al. Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer. J Cancer Res Clin Oncol 141, 1353–1361 (2015). https://doi.org/10.1007/s00432-014-1903-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-014-1903-0